Related Experiment Video

Updated: May 27, 2026

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

Role of antibodies in cancer targeting

Husain Attarwala1

  • 1Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA, USA.

Journal of Natural Science, Biology, and Medicine
|November 19, 2011
PubMed

Insights

Antibody engineering advances enable targeted cancer therapies. These strategies improve chemotherapy and diagnosis by specifically targeting tumor cells, minimizing harm to healthy tissues.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Chemotherapeutic agents often lack specificity, harming both cancerous and normal cells.
  • Targeted drug delivery systems are crucial for enhancing cancer cell elimination while sparing healthy tissues.
  • Advances in antibody engineering offer new possibilities for tumor-targeted strategies.

Purpose of the Study:

  • To review the role of antibodies in cancer diagnosis, chemoprevention, and chemotherapy.
  • To highlight recent advancements in antibody engineering for cancer treatment and detection.

Main Methods:

  • Review of current literature on antibody engineering and cancer therapy.
  • Analysis of antibody-associated tumor-targeted delivery systems.
  • Discussion of applications in chemotherapy, chemoprevention, and diagnosis.

Main Results:

  • Antibody engineering has enabled the development of targeted delivery systems.
  • These systems show potential for specific cancer cell elimination.
  • Applications span diagnosis, prevention, and treatment of cancer.

Conclusions:

  • Antibodies are pivotal in developing targeted cancer therapies.
  • Recent antibody engineering breakthroughs are enhancing cancer treatment efficacy and specificity.
  • Targeted antibody-based strategies represent a significant advancement in oncology.
Keywords:
Antibody engineeringcancer diagnosiscancer targetingchemopreventionchemotherapy

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...